CHG

518

-1.52%↓

CHG

518

-1.52%↓

CHG

518

-1.52%↓

CHG

518

-1.52%↓

CHG

518

-1.52%↓

Search

Halma PLC

Închisă

SectorSectorul industrial

3,706

Rezumat

Modificarea prețului

24h

Curent

Minim

3672

Maxim

3736

Indicatori cheie

By Trading Economics

Venit

107M

187M

Vânzări

651M

1.2B

P/E

Medie Sector

39.517

49.893

EPS

0.553

Randament dividend

0.64

Marjă de profit

15.096

Angajați

9,000

EBITDA

184M

317M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+1.33% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.64%

2.04%

Data viitoare de dividende

30 ian. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-212M

14B

Deschiderea anterioară

3706

Închiderea anterioară

3706

Sentimentul știrilor

By Acuity

85%

15%

417 / 430 Clasament în Industrials

Halma PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 ian. 2026, 21:55 UTC

Câștiguri

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22 ian. 2026, 23:52 UTC

Câștiguri

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22 ian. 2026, 23:48 UTC

Market Talk

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22 ian. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22 ian. 2026, 23:40 UTC

Market Talk

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22 ian. 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 ian. 2026, 23:30 UTC

Market Talk

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22 ian. 2026, 22:37 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22 ian. 2026, 21:59 UTC

Achiziții, Fuziuni, Preluări

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22 ian. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

22 ian. 2026, 21:44 UTC

Câștiguri

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22 ian. 2026, 21:32 UTC

Achiziții, Fuziuni, Preluări

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22 ian. 2026, 21:31 UTC

Achiziții, Fuziuni, Preluări

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22 ian. 2026, 21:31 UTC

Achiziții, Fuziuni, Preluări

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22 ian. 2026, 21:30 UTC

Achiziții, Fuziuni, Preluări

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22 ian. 2026, 21:30 UTC

Câștiguri

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22 ian. 2026, 21:30 UTC

Achiziții, Fuziuni, Preluări

Capital One To Acquire Brex >COF

22 ian. 2026, 21:13 UTC

Câștiguri

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22 ian. 2026, 21:11 UTC

Câștiguri

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 ian. 2026, 21:11 UTC

Câștiguri

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 ian. 2026, 21:10 UTC

Câștiguri

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 ian. 2026, 21:06 UTC

Câștiguri

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22 ian. 2026, 21:05 UTC

Câștiguri

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22 ian. 2026, 21:05 UTC

Câștiguri

Capital One 4Q Rev $15.58B >COF

22 ian. 2026, 21:05 UTC

Câștiguri

Capital One 4Q EPS $3.26 >COF

22 ian. 2026, 21:05 UTC

Câștiguri

Capital One 4Q Net Interest Margin 8.26% >COF

22 ian. 2026, 21:05 UTC

Câștiguri

Capital One 4Q Net $2.13B >COF

22 ian. 2026, 21:05 UTC

Câștiguri

Capital One 4Q Adj EPS $3.86 >COF

22 ian. 2026, 21:05 UTC

Câștiguri

Capital One 4Q Net Charge-Offs $3.8B >COF

22 ian. 2026, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q EPS $2.21 >ISRG

Comparație

Modificare preț

Halma PLC Așteptări

Obiectiv de preț

By TipRanks

1.33% sus

Prognoză pe 12 luni

Medie 3,759.41 GBX  1.33%

Maxim 4,200 GBX

Minim 2,490 GBX

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHalma PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

13 ratings

7

Cumpărare

5

Păstrare

1

Vânzare

Sentiment

By Acuity

417 / 430 Clasament în Sectorul industrial

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Halma PLC

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
help-icon Live chat